A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC

Clinical trial NCT06617416 · RECRUITING

Trial details

NCT number: NCT06617416
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)

Start date: 2024-11-12
Primary completion: 2026-10-28
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.